| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.005 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |